Core Insights - The company reported a stable total revenue of 358 million yuan for the first half of the 2026 fiscal year, reflecting a year-on-year growth of 8.7% [1] - Significant progress has been made in the "AI + Public Health" layout, with services covering nearly 30 provinces and cities, and 44 healthcare regulatory agencies [1] - The company has established 27 million resident health records, creating a solid public health service network [1] Financial Performance - The quality of earnings has significantly improved, with adjusted EBITDA doubling year-on-year to 54 million yuan, nearing breakeven on the financial statements [1] - The company achieved this financial milestone a year ahead of management expectations [1] - New orders in the big data platform and life sciences solutions segments grew by 19.7% and 61.1% respectively, providing ongoing momentum for future development [1] Strategic Positioning - The company is deeply involved in the construction of the National AI Application Center in the medical field in Beijing, highlighting its important role in national-level medical AI projects [1] - This strategic positioning aligns with the company's large model technology entering the "scale landing" phase, showcasing the integration of technological innovation with public service [1] - The report indicates that the company is effectively combining its technological advantages with public service needs, expanding the social value boundaries of medical AI while achieving commercial value [1]
医渡科技2026财年中期业绩：AI+公共健康布局深化，服务网络覆盖30省市